First Business Financial Services Inc. Sells 240 Shares of Merck & Co., Inc. (NYSE:MRK)

Share on StockTwits

First Business Financial Services Inc. cut its holdings in shares of Merck & Co., Inc. (NYSE:MRK) by 3.1% in the 3rd quarter, Holdings Channel reports. The firm owned 7,532 shares of the company’s stock after selling 240 shares during the period. First Business Financial Services Inc.’s holdings in Merck & Co., Inc. were worth $634,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Taylor Hoffman Wealth Management lifted its stake in Merck & Co., Inc. by 24.2% during the third quarter. Taylor Hoffman Wealth Management now owns 15,380 shares of the company’s stock worth $1,295,000 after purchasing an additional 3,000 shares during the last quarter. Benjamin Edwards Inc. lifted its stake in Merck & Co., Inc. by 17.2% during the third quarter. Benjamin Edwards Inc. now owns 1,903 shares of the company’s stock worth $160,000 after purchasing an additional 279 shares during the last quarter. Hayek Kallen Investment Management lifted its stake in Merck & Co., Inc. by 2.9% during the third quarter. Hayek Kallen Investment Management now owns 17,941 shares of the company’s stock worth $1,510,000 after purchasing an additional 508 shares during the last quarter. Whitnell & Co. lifted its stake in shares of Merck & Co., Inc. by 33.6% in the 3rd quarter. Whitnell & Co. now owns 19,865 shares of the company’s stock valued at $1,672,000 after acquiring an additional 5,000 shares during the last quarter. Finally, Lenox Wealth Management Inc. lifted its stake in shares of Merck & Co., Inc. by 23.3% in the 3rd quarter. Lenox Wealth Management Inc. now owns 793 shares of the company’s stock valued at $67,000 after acquiring an additional 150 shares during the last quarter. Hedge funds and other institutional investors own 74.95% of the company’s stock.

NYSE MRK traded up $0.71 on Friday, reaching $83.59. The company had a trading volume of 6,053,527 shares, compared to its average volume of 10,105,755. The firm has a market cap of $212.31 billion, a price-to-earnings ratio of 19.26, a P/E/G ratio of 1.80 and a beta of 0.54. Merck & Co., Inc. has a fifty-two week low of $70.89 and a fifty-two week high of $87.35. The business has a 50 day moving average of $84.01 and a two-hundred day moving average of $82.77. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.21 and a quick ratio of 0.92.

Merck & Co., Inc. (NYSE:MRK) last issued its quarterly earnings results on Tuesday, October 29th. The company reported $1.51 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.24 by $0.27. Merck & Co., Inc. had a return on equity of 47.94% and a net margin of 20.26%. The firm had revenue of $12.40 billion during the quarter, compared to the consensus estimate of $11.59 billion. During the same period last year, the business posted $1.19 EPS. The business’s revenue was up 14.9% compared to the same quarter last year. As a group, research analysts predict that Merck & Co., Inc. will post 5.16 earnings per share for the current fiscal year.

A number of research analysts have recently commented on the company. Bank of America assumed coverage on Merck & Co., Inc. in a research note on Wednesday, October 16th. They issued a “neutral” rating and a $90.00 price target for the company. Leerink Swann assumed coverage on Merck & Co., Inc. in a research note on Thursday, August 15th. They issued an “outperform” rating and a $103.00 price target for the company. Svb Leerink assumed coverage on Merck & Co., Inc. in a research note on Friday, August 16th. They issued an “outperform” rating and a $103.00 price target for the company. Credit Suisse Group reiterated a “buy” rating and issued a $95.00 price target on shares of Merck & Co., Inc. in a research note on Wednesday, August 7th. Finally, ValuEngine cut Merck & Co., Inc. from a “hold” rating to a “sell” rating in a research note on Wednesday, October 2nd. One analyst has rated the stock with a sell rating, three have issued a hold rating and thirteen have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $95.13.

Merck & Co., Inc. Profile

Merck & Co, Inc provides healthcare solutions worldwide. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases.

Recommended Story: NASDAQ Stock Market Explained

Want to see what other hedge funds are holding MRK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck & Co., Inc. (NYSE:MRK).

Institutional Ownership by Quarter for Merck & Co., Inc. (NYSE:MRK)

Receive News & Ratings for Merck & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Private Ocean LLC Buys New Shares in L3Harris
Private Ocean LLC Buys New Shares in L3Harris
SG Americas Securities LLC Sells 49,171 Shares of Intuit Inc.
SG Americas Securities LLC Sells 49,171 Shares of Intuit Inc.
First Business Financial Services Inc. Sells 96 Shares of Chevron Co.
First Business Financial Services Inc. Sells 96 Shares of Chevron Co.
iShares MSCI EAFE ETF  is First Business Financial Services Inc.’s 8th Largest Position
iShares MSCI EAFE ETF is First Business Financial Services Inc.’s 8th Largest Position
First Business Financial Services Inc. Sells 240 Shares of Merck & Co., Inc.
First Business Financial Services Inc. Sells 240 Shares of Merck & Co., Inc.
Wells Fargo & Co  Shares Sold by Hayek Kallen Investment Management
Wells Fargo & Co Shares Sold by Hayek Kallen Investment Management


© 2006-2019 Ticker Report